Xtl Biopharmaceuticals Stock Price To Earning
XTLB Stock | ILS 5.80 0.60 11.54% |
XTL Biopharmaceuticals fundamentals help investors to digest information that contributes to XTL Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of XTL Stock. The fundamental analysis module provides a way to measure XTL Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to XTL Biopharmaceutica stock.
XTL |
XTL Biopharmaceuticals Company Price To Earning Analysis
XTL Biopharmaceutica's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current XTL Biopharmaceutica Price To Earning | 558.33 X |
Most of XTL Biopharmaceutica's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XTL Biopharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Based on the latest financial disclosure, XTL Biopharmaceuticals has a Price To Earning of 558 times. This is much higher than that of the sector and significantly higher than that of the Price To Earning industry. The price to earning for all Israel stocks is notably lower than that of the firm.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
XTL Fundamentals
Return On Equity | 0.38 | |||
Return On Asset | -0.1 | |||
Current Valuation | 61.84 M | |||
Shares Outstanding | 514.21 M | |||
Shares Owned By Insiders | 16.20 % | |||
Price To Earning | 558.33 X | |||
EBITDA | (940 K) | |||
Net Income | 435 K | |||
Cash And Equivalents | 5.06 M | |||
Cash Per Share | 0.01 X | |||
Current Ratio | 51.07 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (1.05 M) | |||
Beta | 1.03 | |||
Market Capitalization | 236.53 K |
About XTL Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XTL Biopharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XTL Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XTL Biopharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in XTL Stock
XTL Biopharmaceutica financial ratios help investors to determine whether XTL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTL with respect to the benefits of owning XTL Biopharmaceutica security.